The targetability of cancer secreted IGF-II and its self-stimulating loop with the insulin receptor in cancer has been exploited in our review article published on the journal “Cancers” [IF 6.162]
The targetability of cancer secreted IGF-II and its self-stimulating loop with the insulin receptor in cancer has been exploited in our review article published on the journal “Cancers” [IF 6.162]